The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.40
Bid: 102.40
Ask: 102.60
Change: -2.20 (-2.10%)
Spread: 0.20 (0.195%)
Open: 102.80
High: 102.80
Low: 102.40
Prev. Close: 104.60
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Change to Articles of the Company

18 Jan 2024 07:00

RNS Number : 0787A
Hipgnosis Songs Fund Limited
18 January 2024
 

This announcement contains inside information for the purposes of UK Market Abuse Regulation

 

 18 January 2024

LEI: 213800XJIPNDVKXMOC11

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Proposed Change to Articles of the Company

 

The Board of Hipgnosis Songs Fund announces that it will publish a circular (the "Circular") to propose that the Articles of the Company are amended, by way of a special resolution (the "Resolution"), to enshrine the payment of a fee, at the Board's discretion, of up to £20 million (in aggregate) by the Company to any prospective bidder(s) who approaches the Board seeking to make an acquisition of the assets of the Company on terms recommendable by the Board to shareholders.

 

Introduction and Background to the Proposal

At the Company's Annual General Meeting convened on 26 October 2023, shareholders of the Company ("Shareholders") overwhelmingly voted against the Company continuing its business as a closed-ended investment company.

Shareholders also overwhelmingly voted against the proposed sale of a portfolio of 29 music catalogues for aggregate cash consideration of $440 million to Hipgnosis Songs Capital ("HSC") at the Extraordinary General Meeting held on the same day. HSC is the trading name of Hipgnosis SC IV (Delaware) L.P., a limited partnership represented by its general partner which is indirectly controlled by Blackstone Inc. and advised by Hipgnosis Song Management Limited ("Hipgnosis Song Management"). Hipgnosis Song Management is also the Company's investment adviser ("Investment Adviser").

Following these shareholder votes, the composition of the Board of directors of the Company underwent significant change to form a Newly Constituted Board. The Newly Constituted Board is conducting a strategic review, announced on 26 October 2023, looking at all options to be considered for the future of the Company, with the aim of maximising value for shareholders.

The Newly Constituted Board has undertaken a substantial investor consultation exercise, having engaged with shareholders holding more than 60% of the Company's shares. One of the key themes of these consultations was shareholders' concern around the Investment Adviser's "Call Option", which gives the Investment Adviser the right to purchase the portfolio upon termination of the Investment Advisory Agreement. Shareholders have told the Board that the Call Option constitutes a material conflict of interest for the Investment Adviser and acts as a significant deterrent to any third-party potential offerors who might seek to acquire the Company or its assets. The Board believes that the Investment Adviser's Call Option therefore depresses the potential value of the Company by limiting certain possible opportunities for Shareholder value creation.

The Board therefore proposes that the Articles of the Company are amended, by way of a special resolution, to:

· enshrine the payment of a fee of up to £20 million (in aggregate) by the Company, at the Board's discretion, to any prospective offeror(s) who may approach the Board seeking to make an acquisition of one or more of its subsidiaries which own the majority of the Company's music assets, and/or all or some of the Company's assets, on terms recommendable by the Board to Shareholders; and

· the extent permissible by UK Takeover Code issued by the Panel on Takeovers and Mergers, as amended from time to time, authorise the payment(s) and/or reimbursement(s) by the Company of up to a maximum aggregate amount of £20 million to bona fide prospective offeror(s) for the entire issued share capital of the Company on terms recommendable by the Board to Shareholders

(together, the "Proposal").

The Newly Constituted Board considers that the Proposal will provide significant protection to prospective offerors against their due diligence and acquisition costs, up to a maximum of £20 million (in aggregate), to ensure that they are not deterred from seeking to engage with the Company regarding a recommendable offer for the Company's assets as a result of the terms of the Investment Adviser's Call Option.

The Newly Constituted Board therefore considers that the Proposal will provide greater potential opportunities to maximise value for Shareholders. Specifically in relation to the Proposal, the Newly Constituted Board has consulted with several of the Company's largest shareholders, holding in aggregate more than 35% of the issued share capital and all whom have indicated their support for the Proposal. The Strategic Review is ongoing, and the Board is not actively seeking one or more potential offers for the Company.

 

Notice of the Extraordinary General Meeting

A circular, containing further details of the Proposal and the Call Option and a notice convening the Extraordinary General Meeting in order to pass the Resolution is expected to be dispatched to Shareholders in due course.

The Circular will set out the background to and reasons for the Proposal and the reasons why the Directors, having consulted its financial adviser and broker Singer Capital Markets, consider the Proposal to be in the best interests of the Company, having regard to the interests of its Shareholders as a whole, and recommend that Shareholders vote in favour of the Resolution as they intend to do in respect of their shareholdings. A further announcement will be published in due course.

 

Robert Naylor, Chairman of Hipgnosis Songs Fund Limited, said:

"Investors in Hipgnosis Songs Fund overwhelmingly voted for change when they rejected the continuation of the Company and the proposed sale of certain music assets.

"From our shareholder consultation, core to the requirement for change is addressing the Call Option held by our Investment Adviser, Hipgnosis Songs Management. This not only acts as a structural conflict between the interests of our shareholders and the Investment Adviser, but also creates a significant deterrent to potential bidders for the Company's assets thereby depressing the value of the Company.

"It is against this backdrop that we are proposing to change our Articles to allow potential bidders to put forward their proposals for the Company's assets, with significant cost protection, if supported by a Board recommendation to shareholders. We are pleased, having discussed this proposal with many of our largest shareholders, that they are supportive of the Board's efforts to unlock the full value from the Company's assets. The newly constituted board believes it is essential to try to level the playing field so shareholder value can be maximised."

The person responsible for making this notification is Robert Naylor, Chairman of Hipgnosis Songs Fund Limited.

 

For further information please contact:Hipgnosis Songs Fund

Robert Naylor

Via Singer Capital Markets

 

 

 

+44 (0) 20 7496 3000

 

 

Singer Capital Markets - Corporate Broker

James Moat / Alaina Wong / Angus Campbell (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

 

+44 (0) 20 7496 3000

Headland Consultancy - Financial PR

Susanna Voyle / Charlie Twigg

 

+44 (0) 20 3805 4822

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDQKOBKNBKBNDD
Date   Source Headline
19th Apr 202411:20 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
19th Apr 202410:38 amRNSForm 8.5 (EPT/RI)
19th Apr 202410:38 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 20243:40 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 20241:17 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 202411:14 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 202410:26 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
18th Apr 20247:00 amRNSRECOMMENDED CASH OFFER FOR HIPGNOSIS
15th Apr 20247:00 amRNSChange to Director roles and responsibilities
28th Mar 20249:02 amRNSFinal Due Diligence Findings
18th Mar 20247:00 amRNSAmendment to Operative Net Asset Value
4th Mar 20249:27 amRNSUpdate on Due Diligence, Valuation and NAV
4th Mar 20247:00 amRNSUpdate on Due Diligence, Valuation and NAV
26th Feb 20247:00 amRNSLitigation update
19th Feb 20247:00 amRNSLitigation Update
7th Feb 202412:35 pmRNSResult of Extraordinary General Meeting (“EGM”)
5th Feb 20247:00 amRNSLitigation Update
23rd Jan 20247:00 amRNSPublication of Circular/Update to Strategic Review
18th Jan 20247:00 amRNSProposed Change to Articles of the Company
11th Jan 20247:00 amRNSDirectorate Change
4th Jan 20243:26 pmRNSHolding(s) in Company
21st Dec 20237:00 amRNSInterim results to 30 September 2023
20th Dec 20237:00 amRNSChange of Auditor
19th Dec 20237:00 amRNSDelay to publication of interim results
15th Dec 20237:00 amRNSDirectorate Change
11th Dec 20237:00 amRNSAsset sale, adviser appointment, notice of results
28th Nov 202312:52 pmRNSHolding(s) in Company
23rd Nov 20237:00 amRNSStrategic Review and Company Update
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20237:00 amRNSDirectorate Changes
6th Nov 20237:00 amRNSUpdate on dividend intentions
26th Oct 202311:20 amRNSResult of AGM and EGM
25th Oct 20234:00 pmRNSDirectorate Changes, withdrawal of AGM Resolutions
24th Oct 20237:00 amRNSConclusion of Go-Shop process
19th Oct 20237:00 amRNSInitiation of Strategic Review, update on RCF
17th Oct 202312:22 pmRNSHolding(s) in Company
17th Oct 202312:21 pmRNSHolding(s) in Company
17th Oct 202312:18 pmRNSHolding(s) in Company
16th Oct 20236:17 pmRNSUpdate on CRB III and dividend payment
16th Oct 20237:13 amRNSUpdate on CRB III impact and dividend payment
28th Sep 202311:07 amRNSPublication of Circular and Notice of AGM & EGM
25th Sep 20232:41 pmRNSHolding(s) in Company
22nd Sep 202310:49 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSDividend Declaration
20th Sep 20237:00 amRNSHolding(s) in Company
14th Sep 20237:00 amRNSAsset sales to fund buy backs and reduce debt
14th Aug 202312:29 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAnnual Financial Report
10th Jul 20237:00 amRNSDirectorate Change and Notice of Results
23rd Jun 202312:02 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.